Antibodies, antigens, and anticoagulants: a historical review of a lifetime in transfusion medicine—the Landsteiner Lecture 2004

Artificial Oxygen Carriers—Past, Present, and Future—a Review of the Most Innovative and Clinically Relevant Concepts

“…On September 1, 1818, the first blood transfusion from human to human was performed by Blundell (1818). However, only with the discovery of the ABO blood type by Landsteiner and Decastello survival improved (Greenwalt, 2005).…”

‘Pinholes in my arms’: the vicious cycle of vascular access

“…Since then, there have been rapid advancements in techniques, technologies, and methods of intravenous (IV) access and therapy. IV therapy has continued to evolve into the twentieth century, particularly in the fields of blood transfusion, saline solutions, and nutritional support (Greenwalt, 2005;Stansbury and Hess, 2010). Such transfusions soon became widely accepted into practice and, as the field of IV therapy developed, the vascular access devices (VAD) used to deliver the therapies also began to evolve .…”

Proteomics and transfusion medicine: Future perspectives

“…However, after ultracentrifugation, it was shown that the three-quarters of the apparent hemolysis was actually encapsulated microvesicles [117,118]. Moreover, as quoted by T. J. Greenwalt himself [119], until then, there has been very little interest in the subject in the American transfusion medicine community. However, the formation of vesicles from erythrocytes has been a subject of intensive research in Europe (reviewed in [118]).…”